Rankings
▼
Calendar
BEAM Q1 2024 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
-69.4% YoY
Gross Profit
-$77M
-1044.6% margin
Operating Income
-$104M
-1405.3% margin
Net Income
-$99M
-1331.6% margin
EPS (Diluted)
$-1.21
QoQ Revenue Growth
-97.7%
Cash Flow
Operating Cash Flow
-$100M
Free Cash Flow
-$102M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$1.4B
Total Liabilities
$446M
Stockholders' Equity
$913M
Cash & Equivalents
$288M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$24M
-69.4%
Gross Profit
-$77M
-$75M
-2.6%
Operating Income
-$104M
-$99M
-5.3%
Net Income
-$99M
-$96M
-2.3%
← FY 2024
All Quarters
Q2 2024 →